Top Markets
#1 Helium Helium +49.60%
#2 TENDIES TENDIES +38.23%
#3 Seeker Seeker +21.88%
#4 Pons Pons +16.20%
#5 UnifAI Network UnifAI Network +14.15%
#6 Songbird Songbird +12.10%
#7 OSK OSK +9.90%
#8 Audiera Audiera +9.82%
#9 Lista DAO Lista DAO +9.42%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +8.51%
Coin of the day
Helium Helium
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Chongqing Lummy Pharmaceutical Co., Ltd. Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd.

300006
Kedudukan dalam Saham #10090
Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the... Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the research, development, production, and distribution of a broad spectrum of pharmaceutical products. Its extensive portfolio encompasses treatments for various therapeutic areas, including oncology, infectious diseases (antibacterial, antiviral, and antifungal), liver support, and endocrine disorders. The company also develops and markets medications for the digestive, immune, blood, cardiovascular, and nervous systems, in addition to traditional Chinese patent medicines. Further offerings include electrolyte and acid-base balancing agents, nutritional supplements, large volume parenteral solutions, American ginseng preparations, and active pharmaceutical ingredients. Established in 1999, the company's headquarters are located in Chongqing, China.
Harga Saham
$0.84484795
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$892.08M
Perubahan (1 hari)
-4.11%
Perubahan (1 tahun)
27.37%
Negara
CN
Perdagangan Chongqing Lummy Pharmaceutical Co., Ltd. (300006)

Kategori

Healthcare
Pendapatan untuk Chongqing Lummy Pharmaceutical Co., Ltd. (300006)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Chongqing Lummy Pharmaceutical Co., Ltd., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Chongqing Lummy Pharmaceutical Co., Ltd. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US